The Combined Effect of Interferon-β and Cytostatic Drugs on Human Tumor Cell Lines In Vitro

Publisher Website
Google Scholar
Abstract
Three human tumor cell lines (one osteosarcoma and two neuroblastoma lines) were assessed for combined interferon-β (IFN-β)/chemotherapeutic drug antigrowth effect under in vitro conditions. Two different methods to measure this effect were used: colony formation in soft agar and counting of cells growing as monolayers. The cells were incubated with a chemotherapeutic drug (adriamycin, dacarbazine, actinomycin D, cis-platinum, methotrexate, VP-16-213, or vincristine) at relevant concentrations for 1 h, washed twice, and incubated with IFN-β in concentrations ranging from 100 to 1000 IU for continuous exposure. All combinations resulted in an additive or synergistic combination effect with one exception: methotrexate/IFN-β in the monolayer method after 1 week, a combination which was additive after 3 weeks however. The combinations VP-16-213/IFN-β and cisplatinum/IFN-β produced the most pronounced synergistic effects. A statistical evaluation of the null hypothesis for additivity was done. These results provide a rationale for designing clinical studies combining IFN-β with current chemotherapeutic drugs.